MobileODT is the only company that brings the power of AI into cervical cancer screening, while supporting the World Health Organization strategic mission to eliminate cervical cancer till 2050.

Our strategic vision is to evolve into a digital health company that is revolutionizing FemTech with AI technology, making an impact and changing women’s health diagnosing at the point of care.


Our Representatives

Noam Sorek

VP Sales, MobileODT

VP Sales

MobileODT

OUR MISSION To equip women’s healthcare providers with advanced AI medical device technologies for the detection of cervical cancer Cervical cancer is the fourth most commo...

Company Solutions

Digital Innovation for Colposcopy

Take your cervical examination to the next level –be at the forefront of women’s health wtih EVA COLPO.

  • VisualCheck
  • AI clinical decision support for assessing cervical cancer
  • VisualCheck* provides clinicians with AI (Augmented Intelligence) clinical decision support technology to assess for normal and abnormal cervical findings. Using a complex algorithm, VisualCheck predicts how highly trained colposcopists determine findings of the cervix.
  • The algorithm is trained on thousands of images of the cervix that top colposcopists in the US have annotated.

AT THE POINT OF CARE

VisualCheck & the EVA System combine to provide high quality visualization and quality controls for any location
SAVE TIME

AI answers are provided quickly to improve the time management of patient visits

How does VisualCheck work?

VisualCheck runs on the EVA System online portal using the images captured by the device. After completing a standard cervical examination with the EVA colposcope, the clinician will review the images on the portal and run the VisualCheck assessment.

In less than a minute, the clinician will receive a message indicating whether the images are likely to indicate abnormal (suspected positive findings) or normal (no suspected positive findings).

The EVA System AI

We believe that healthcare providers deserve the most advanced AI medical device technologies possible and that no healthcare provider should be restricted from providing patients with the best possible analysis.

By harnessing the power of AI, VisualCheck run on the EVA System will ensure that women across the globe have improved access to a expert level healthcare provider who can give them the high quality of analysis and care.

Augmented Intelligence

MobileODT is committed to harnessing the most advanced technologies to build cutting-edge medical devices for healthcare providers, extending the capabilities of the EVA System to improve access to cervical cancer screening.

Medical-grade Artificial Intelligence (AI) has tremendous promise to support healthcare providers to give better care for their patients. It can give patients the best possible analysis at the right time, enable the healthcare provider to determine the best next steps for that patient, and allow patients to find the resources to address disease.

*Currently not available for sale in the United States.

Looking For

New channels global distribution